Showing results (311-320 of 1,359) with videos related to
Sort By:
Pageof 136
Haemostasis|January 1, 1981
The effects of two different dosage regimens of sulphinpyrazone on platelet function ex vivo and blood chemistry in manE D Maguire, G F Pay, J Turney, et al.Haemostasis|January 1, 1981
Inhibition of activated factors II, VII, IX, and X by synthetic organic compounds directed against the active-site seryl residueJ A Van der Woerd-de Lange, M C van Dam-Mieras, H C HemkerHaemostasis|January 1, 1983
Effects of heparin and alpha 1-acid glycoprotein on thrombin or Activated Thrombofax Reagent-induced platelet aggregation and clot formationB A Fiedel, M Costello, H Gewurz, et al.Haemostasis|January 1, 1981
Clinical and experimental evaluation of the thromboprophylactic effect of hydroxychloroquine sulfate after total hip replacementE Johansson, K Forsberg, H JohnssonHaemostasis|January 1, 1996
American experience with home use of NovoSeven: recombinant factor VIIa in hemophiliacs with inhibitorsA D ShapiroHaemostasis|January 1, 1980
De novo synthesis of purine nucleotides in human blood plateletsZ Jerushalmy, M Patya, P Boer, et al.Haemostasis|January 1, 1979
Investigations on intravascular coagulation in liver disease: souble fibrin monomer complexes in liver cirrhosisS Coccheri, G Palareti, P R Dalmonte, et al.Haemostasis|January 1, 1986
Studies in rats on in vitro inhibition and in vivo activity of vitamin-K-dependent carboxylationD M Cocchetto, T D BjornssonHaemostasis|January 1, 1989
Distinctive features of procoagulant response of monocytes from diabetic patientsB Jude, A Watel, O Fontaine, et al.Haemostasis|January 1, 1989
Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory studyJ Carvalho de Sousa, E Bruckert, P Giral, et al.Pageof 136